Showing results (81-90 of 105) with videos related to
Sort By:
Pageof 11
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 15, 2005
Continued gefitinib treatment after disease stabilisation prolongs survival of Japanese patients with non-small-cell lung cancer: Okayama Lung Cancer Study Group experienceK Hotta, K Matsuo, H Ueoka, et al.Nihon Kyobu Shikkan Gakkai Zasshi|December 1, 1996
[Chemotherapy for small-cell lung cancer]H Ueoka, K Kiura, M Tabata, et al.Acta Medica Okayama|June 1, 1993
Immunohistochemical detection of P-glycoprotein and carcinoembryonic antigen in small cell lung cancer: with reference to predictability of response to chemotherapyY Segawa, T Ohnoshi, S Hiraki, et al.Anticancer Research|January 11, 2000
In vitro evaluation of antimicrotubule agents in human small-cell lung cancer cell linesS Ikubo, N Takigawa, H Ueoka, et al.Internal Medicine (Tokyo, Japan)|January 11, 2000
Very young patient with peculiar squamous cell carcinoma of the lungY Emori, K Kiura, T Yoshino, et al.Japanese Journal of Clinical Oncology|February 24, 2001
Prognostic factors in advanced non-small cell lung cancer: elevated serum levels of neuron specific enolase indicate poor prognosisT Maeda, H Ueoka, M Tabata, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 1, 1995
[Induction chemotherapy followed by adjuvant surgery (IC-AS) in patients with stage I-II small cell lung cancer (SCLC)]T Shibayama, J Hiyama, H Ueoka, et al.Nihon Kyobu Shikkan Gakkai Zasshi|June 1, 1992
[Serum neuron specific enolase (NSE) levels in patients with non small cell lung cancer]T Shibayama, T Ohnoshi, H Ueoka, et al.Cancer Research|January 13, 2001
Polymorphisms of UDP-glucuronosyltransferase gene and irinotecan toxicity: a pharmacogenetic analysisY Ando, H Saka, M Ando, et al.Nihon Kyobu Shikkan Gakkai Zasshi|February 1, 1992
[Treatment of small cell lung cancer in the elderly: the progress and limitation of chemotherapy]T Ohnoshi, H Ueoka, N Hino, et al.Pageof 11